Population
Left ventricular samples from 11 patients with end-stage heart failure and 6 organ donors (normal controls)
Design
Case-control
Authors
Loading...
May limit diastolic Ca2+ overload yet promote arrhythmias in end-stage HF; leaves open NCX as therapeutic target.
End-stage heart failure is associated with increased sarcolemmal Na+/Ca2+-exchanger activity and expression, which may limit diastolic Ca2+ overload but potentially enhance arrhythmogenesis.
Reinecke et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: